Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New rapid test could speed up heart attack diagnosis in ER

NCT ID NCT06499519

Diagnosis Sponsor: SpinChip Diagnostics ASA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new blood test called SpinChip hs-cTnI that measures troponin, a protein released during a heart attack. Researchers wanted to see if this test could accurately diagnose heart attacks in 1,551 adults arriving at the emergency room with chest pain or other symptoms. The test was compared to a standard, proven method to check its accuracy and safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,551 people

The number who actually took part.

Started

Jul 2024

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects presenting to the emergency department with acute chest discomfort or other symptoms suggestive of AMI. This multicentre study will be conducted at up to 10 sites in the EU/EEA, Switzerland and UK.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Able and willing to provide signed written informed consent * Subjects ≥ 18 years old * Subjects presenting at the ED with acute chest discomfort including "pain", "pressure", "tightness", "burning", or "stabbing" and/or other symptoms suggestive of AMI such as upper abdominal pain, left shoulder/arm pain, pain in the jaw, or pain between the scapulae. Exclusion Criteria: * Subjects experiencing shock * Self-reported pregnancy * Previously included in the study (e.g., in case of a second presentation) * Patient incapable of judgement, for example due to severe pain

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute myocardial infarction myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute myocardial infarction

Contacts and locations

Locations

  • Aarhus Universitetshospital

    Aarhus, DK-8200, Denmark

  • Akershus University hospital, Akershus Clinical Research Center (ACR)

    Lørenskog, Akerhus, 1474, Norway

  • Danderyd University Hospital

    Danderyd, 182 88, Sweden

  • Haukland University Hospital, Department of Heart Disease

    Bergen, Vestland, 5021, Norway

  • Luzerner Kantonsspital

    Lucerne, 6000, Switzerland

  • Royal Alexandra Hospital

    Paisley, PA2 9PN, United Kingdom

  • Royal Infirmary of Edinburgh

    Edinburgh, EH16 4SB, United Kingdom

  • University hospital Basel, Cardiovascular Research Institute of Basel (CRIB)

    Basel, Basel, 4056, Switzerland

  • Universitätsmedizin Göttingen (University Medical Center Göttingen)

    Göttingen, 37099, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.